Synthetic opioids

This undated photo provided by the Southwest Virginia Regional Jail Authority shows Dr. Joel Smithers. Smithers is facing the possibility of life in prison after being convicted in May of more than 800 counts of illegally prescribing drugs, including oxycodone and oxymorphone that caused the death of a West Virginia woman. When he is sentenced Wednesday, Oct. 2, 2019 the best Smithers can hope for is a mandatory minimum of 20 years.Southwest Virginia Regional Jail Authority) .
1010 WINS Newsroom
September 28, 2019 - 9:37 am
RICHMOND, Va. (AP) — By the time drug enforcement agents swooped into his small medical office in Martinsville, Virginia, in 2017, Dr. Joel Smithers had prescribed about a half a million doses of highly addictive opioids in two years. Patients from five states drove hundreds of miles to see him,...
Read More
FILE - In this Oct. 2, 2016 file photo, Mac Miller performs at the 2016 The Meadows Music and Arts Festivals at Citi Field in Flushing, New York. Authorities say an Arizona man has become the second person arrested on drug charges in the investigation of the overdose death of the rapper. Havasu City, Ariz., police said Tuesday, Sept. 24, 2019, that Ryan Reavis has been charged with possession of marijuana and prescription drugs. (Photo by Scott Roth/Invision/AP, File)
1010 WINS Newsroom
September 25, 2019 - 7:26 pm
LOS ANGELES (AP) — An Arizona man has become the second person arrested on drug charges as authorities investigate the overdose death of rapper Mac Miller. Police gave no details on the connection between him and 26-year-old Miller, who died a year ago in his Los Angeles home of an accidental...
Read More
1010 WINS Newsroom
September 25, 2019 - 4:16 pm
OxyContin maker Purdue Pharma's tentative legal settlement over the toll of the nation's opioid crisis is unlikely to reverse the consequences of the epidemic in the hardest-hit towns and regions, according to a report released Wednesday. Purdue reached a tentative deal this month to resolve the...
Read More
FILE - In this Jan. 17, 2019, file photo, a sign with the Sackler name is displayed at the Metropolitan Museum of Art in New York. Their name used to be on a wing at the Louvre. But now the Sackler family wealth has become linked to sales of OxyContin, and their company, drug maker Purdue Pharma, is attempting to settle lawsuits over the opioid crisis. (AP Photo/Seth Wenig, File)
1010 WINS Newsroom
September 19, 2019 - 5:24 pm
For a family with its name on a wing of one of the world's most famous museums and a school at a prestigious university, members of the Sackler clan have done a remarkable job of vanishing from public life. The family owns OxyContin maker Purdue Pharma, which filed for bankruptcy this week as part...
Read More
FILE - In this Thursday, Sept. 12, 2019 file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. The allegations surrounding wealthy donors such as the Sackler family have raised questions for the museums they supported, including whether to keep the family's name on prominent galleries. The billionaire family is notorious for its ties to the drug company Purdue Pharma, which developed OxyContin, a painkiller that has been at the center of the opioid crisis. (AP Photo/Frank Franklin II, File)
1010 WINS Newsroom
September 18, 2019 - 1:13 am
NEW YORK (AP) — Ask the CEO and president of the Metropolitan Museum of Art whether he's accepting money from the Sacklers, the billionaire dynasty notorious for its ties to the drug company Purdue Pharma, and the answer is somewhat complicated. For one thing, it depends on which Sackler. "There...
Read More
FILE - This May 8, 2007, file photo shows the Purdue Pharma logo at its offices in Stamford, Conn. (AP Photo/Douglas Healey, File)
1010 WINS Newsroom
September 17, 2019 - 7:40 pm
WHITE PLAINS, N.Y. (AP) — A judge cleared the way Tuesday for OxyContin maker Purdue Pharma to stay in business while it pursues bankruptcy protection and settlement of more than 2,600 lawsuits filed against it in a reckoning over the opioid crisis. At the first court hearing since the Chapter 11...
Read More
FILE - In this Aug. 17, 2018, file photo, Lynn Wencus of Wrentham, Mass., holds a sign with a picture of her son Jeff and wears a sign of others' loved ones lost to OxyContin and other opioids during a protest at Purdue Pharma LLP headquarters in Stamford, Conn. Some of the money in Purdue Pharma’s proposed multibillion-dollar opioid settlement would come from the continued sale of opioids. “It’s blood money paying for blood money,” said Wencus. “It’s ludicrous. The whole thing would be almost comical if we weren’t talking about human lives here.” (AP Photo/Jessica Hill, File)
1010 WINS Newsroom
September 17, 2019 - 4:20 pm
The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin. That would amount to blood money, in the opinion of some critics. And it's one reason two dozen states have rejected the deal. "The...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
1010 WINS Newsroom
September 17, 2019 - 7:29 am
NEW YORK (AP) — Purdue Pharma gets its day in court Tuesday after the OxyContin maker filed for bankruptcy and negotiated a potential multi-billion dollar settlement to resolve thousands of lawsuits. An initial hearing will be held in federal court in White Plains, New York, for the Chapter 11...
Read More
FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Purdue Pharma, the company which makes OxyContin and other drugs, filed court papers in New York on Sunday, Sept. 15, 2019, seeking Chapter 11 bankruptcy protection. (AP Photo/Toby Talbot, File)
1010 WINS Newsroom
September 16, 2019 - 4:48 pm
BOSTON (AP) — OxyContin maker Purdue Pharma has embarked on a multibillion-dollar plan to settle thousands of lawsuits over the nation's deadly opioid crisis by transforming itself in bankruptcy court into a sort of hybrid between a business and a charity. Whether the company can pull it off...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
1010 WINS Newsroom
September 15, 2019 - 11:46 pm
Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy in White Plains, New York, days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids. The filing was anticipated before...
Read More

Pages